1. Home
  2. YHC vs PTIX Comparison

YHC vs PTIX Comparison

Compare YHC & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YHC
  • PTIX
  • Stock Information
  • Founded
  • YHC 2021
  • PTIX 1994
  • Country
  • YHC United States
  • PTIX United States
  • Employees
  • YHC N/A
  • PTIX N/A
  • Industry
  • YHC Beverages (Production/Distribution)
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • YHC Consumer Staples
  • PTIX Health Care
  • Exchange
  • YHC Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • YHC 1.4M
  • PTIX 1.9M
  • IPO Year
  • YHC N/A
  • PTIX 2016
  • Fundamental
  • Price
  • YHC $1.27
  • PTIX $3.80
  • Analyst Decision
  • YHC Strong Buy
  • PTIX
  • Analyst Count
  • YHC 1
  • PTIX 0
  • Target Price
  • YHC $175.00
  • PTIX N/A
  • AVG Volume (30 Days)
  • YHC 3.4M
  • PTIX 5.6M
  • Earning Date
  • YHC 05-13-2025
  • PTIX 05-13-2025
  • Dividend Yield
  • YHC N/A
  • PTIX N/A
  • EPS Growth
  • YHC N/A
  • PTIX N/A
  • EPS
  • YHC N/A
  • PTIX N/A
  • Revenue
  • YHC $2,449,906.00
  • PTIX N/A
  • Revenue This Year
  • YHC $69.97
  • PTIX N/A
  • Revenue Next Year
  • YHC $403.29
  • PTIX N/A
  • P/E Ratio
  • YHC N/A
  • PTIX N/A
  • Revenue Growth
  • YHC 68.83
  • PTIX N/A
  • 52 Week Low
  • YHC $1.21
  • PTIX $2.35
  • 52 Week High
  • YHC $98.00
  • PTIX $19.32
  • Technical
  • Relative Strength Index (RSI)
  • YHC N/A
  • PTIX 47.89
  • Support Level
  • YHC N/A
  • PTIX $3.71
  • Resistance Level
  • YHC N/A
  • PTIX $4.47
  • Average True Range (ATR)
  • YHC 0.00
  • PTIX 1.40
  • MACD
  • YHC 0.00
  • PTIX -0.17
  • Stochastic Oscillator
  • YHC 0.00
  • PTIX 8.58

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: